Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

April 30, 2010

Conditions
Celiac Disease
Interventions
DRUG

Larazotide acetate

gelatin capsule

DRUG

Placebo

gelatin capsule

DIETARY_SUPPLEMENT

Gluten 900 mg

gelatin capsule

Trial Locations (15)

Unknown

Study Site, Orange

Study Site, Topeka

Study Site, Lexington

Study Site, Hagerstown

Study Site, Silver Spring

Study Site, Chesterfield

Study Site, Troy

Study Site, Rochester

Study Site, New York

Study Site, Oklahoma City

Study Site, Paoli

Study Site, Philadelphia

Study Site, Pittsburgh

Study Site, Franklin

Study Site, Edmonton

Sponsors
All Listed Sponsors
lead

9 Meters Biopharma, Inc.

INDUSTRY

NCT00889473 - Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease | Biotech Hunter | Biotech Hunter